Kemin Jin

789 total citations · 1 hit paper
34 papers, 502 citations indexed

About

Kemin Jin is a scholar working on Oncology, Hepatology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kemin Jin has authored 34 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Oncology, 20 papers in Hepatology and 12 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kemin Jin's work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Kemin Jin is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Colorectal Cancer Treatments and Studies (16 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (11 papers). Kemin Jin collaborates with scholars based in China, Ethiopia and Philippines. Kemin Jin's co-authors include Baocai Xing, Kun Wang, Quan Bao, Xiaoluan Yan, Xiaojuan Du, Min Lu, Chunfeng Zhang, Yu Wang, Hongwei Wang and Wei Zhao and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Cancer Cell.

In The Last Decade

Kemin Jin

34 papers receiving 497 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial

2025 17 citations Hongwei Wang, Qun Ma et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kemin Jin China	10	249	205	176	121	81	34	502
Ruo‐Yu Guan China	13	128 0.5×	202 1.0×	144 0.8×	159 1.3×	98 1.2×	27	482
Wen-Kai Shi China	5	102 0.4×	212 1.0×	148 0.8×	185 1.5×	61 0.8×	8	435
Dianke Chen China	13	186 0.7×	299 1.5×	54 0.3×	257 2.1×	53 0.7×	25	519
Bao‐Ye Sun China	12	104 0.4×	169 0.8×	70 0.4×	136 1.1×	49 0.6×	22	370
Zhiming Wang China	15	154 0.6×	402 2.0×	80 0.5×	320 2.6×	41 0.5×	32	638
Hideaki Oe Japan	8	94 0.4×	203 1.0×	103 0.6×	163 1.3×	65 0.8×	18	382
Jiangfeng Xu China	11	71 0.3×	289 1.4×	84 0.5×	235 1.9×	67 0.8×	18	486
Di‐Peng Ou China	11	137 0.6×	279 1.4×	268 1.5×	182 1.5×	126 1.6×	14	628
Anna Elisabetta Brunetti Italy	10	175 0.7×	138 0.7×	44 0.3×	60 0.5×	39 0.5×	18	336

Countries citing papers authored by Kemin Jin

Since Specialization

Citations

This map shows the geographic impact of Kemin Jin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kemin Jin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kemin Jin more than expected).

Fields of papers citing papers by Kemin Jin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kemin Jin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kemin Jin. The network helps show where Kemin Jin may publish in the future.

Co-authorship network of co-authors of Kemin Jin

This figure shows the co-authorship network connecting the top 25 collaborators of Kemin Jin. A scholar is included among the top collaborators of Kemin Jin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kemin Jin. Kemin Jin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Hongwei, Qun Ma, Kemin Jin, et al.. (2025). The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial. Nature Communications. 16(1). 1443–1443. 17 indexed citations breakdown →

Hu, Yang, Muhua Chen, Shiqi Sun, et al.. (2025). Long non-coding RNA LINC01532 sustains redox homeostasis and accelerates lenvatinib resistance in hepatocellular carcinoma. Journal of Advanced Research. 78. 589–605. 4 indexed citations

Bao, Quan, Tingting Zhao, Longfei Huang, et al.. (2024). Pre-hepatectomy dynamic circulating tumor DNA to predict pathologic response to preoperative chemotherapy and post-hepatectomy recurrence in patients with colorectal liver metastases. Hepatology International. 18(3). 1029–1039. 4 indexed citations

Yan, Xiaoluan, Hongwei Wang, Kemin Jin, et al.. (2023). Five‐year survival post hepatectomy for colorectal liver metastases in a real‐world Chinese cohort: Recurrence patterns and prediction for potential cure. Cancer Medicine. 12(8). 9559–9569. 14 indexed citations

Wang, Kun, Quan Bao, Hongwei Wang, et al.. (2023). Efficacy and safety of IBI110 in combination with sintilimab and lenvatinib in first-line of advanced hepatocellular carcinoma: Preliminary results from a phase Ib study.. Journal of Clinical Oncology. 41(16_suppl). 2577–2577. 1 indexed citations

Wang, Hongwei, et al.. (2023). Sintilimab plus Lenvatinib conversion therapy for intermediate/locally advanced hepatocellular carcinoma: A phase 2 study. Frontiers in Oncology. 13. 1115109–1115109. 17 indexed citations

Jin, Kemin, et al.. (2023). Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study. Annals of Surgical Oncology. 30(8). 4916–4926. 9 indexed citations

Wang, Yanyan, Kun Wang, Quan Bao, et al.. (2023). Combined ablation and resection (CARe) for resectable colorectal cancer liver Metastases-A propensity score matching study. European Journal of Surgical Oncology. 49(9). 106931–106931. 6 indexed citations

Bao, Xuanwen, Kun Wang, Ming Liu, et al.. (2022). Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value. Frontiers in Cell and Developmental Biology. 9. 760618–760618. 31 indexed citations

10.

Wang, Hongwei, Kemin Jin, Juan Li, Kun Wang, & Baocai Xing. (2022). Postoperative complications predict poor outcomes only in patients with a low modified clinical score after resection of colorectal liver metastases: a retrospective cohort study. Updates in Surgery. 74(5). 1601–1610. 8 indexed citations

11.

Yan, Xiaoluan, Kun Wang, Quan Bao, et al.. (2021). En bloc right hemicolectomy with pancreatoduodenectomy for right-sided colon cancer invading duodenum. BMC Surgery. 21(1). 302–302. 6 indexed citations

12.

Wang, Hongwei, Xiaoluan Yan, Lijun Wang, et al.. (2021). Characterization of genomic alterations in Chinese colorectal cancer patients with liver metastases. Journal of Translational Medicine. 19(1). 313–313. 8 indexed citations

13.

Wang, Kun, Yanyan Wang, Quan Bao, et al.. (2021). Short- and long-term outcomes of hepatectomy combined with intraoperative radiofrequency ablation for patients with multiple primarily unresectable colorectal liver metastases: a propensity matching analysis. HPB. 23(10). 1586–1594. 10 indexed citations

14.

Wang, Kun, Hongwei Wang, Kemin Jin, et al.. (2021). Mutated DNA Damage Repair Pathways Are Prognostic and Chemosensitivity Markers for Resected Colorectal Cancer Liver Metastases. Frontiers in Oncology. 11. 643375–643375. 3 indexed citations

15.

Jin, Kemin, Kun Wang, Quan Bao, Hongwei Wang, & Baocai Xing. (2020). Liver resection for colorectal liver-limited metastases in elderly patients: a propensity score matching analysis. World Journal of Surgical Oncology. 18(1). 275–275. 9 indexed citations

16.

Wang, Hongwei, et al.. (2020). Comparison of sequential, delayed and simultaneous resection strategies for synchronous colorectal liver metastases. BMC Surgery. 20(1). 16–16. 14 indexed citations

17.

Jin, Kemin, Xiaoluan Yan, Kun Wang, et al.. (2015). [Prognostic significance of clinical risk score system after resection of hepatic metastases from colorectal cancer].. PubMed. 37(12). 913–6. 1 indexed citations

18.

Jin, Ye, Li Zhou, Zhiyong Liang, et al.. (2015). Clinicopathologic and Prognostic Significance of Carboxyl Terminus of Hsp70-interacting Protein in HBV-related Hepatocellular Carcinoma. Asian Pacific Journal of Cancer Prevention. 16(9). 3709–3713. 3 indexed citations

19.

Zhao, Wei, Haibo Han, Kemin Jin, et al.. (2013). 1B50-1, a mAb Raised against Recurrent Tumor Cells, Targets Liver Tumor-Initiating Cells by Binding to the Calcium Channel α2δ1 Subunit. Cancer Cell. 23(4). 541–556. 133 indexed citations

20.

Jin, Kemin, Min Lu, Fangfang Liu, et al.. (2012). N-WASP is highly expressed in hepatocellular carcinoma and associated with poor prognosis. Surgery. 153(4). 518–525. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact